ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 89 filers reported holding ARATANA THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $7,183,000 | -14.2% | 1,365,570 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $8,371,000 | -11.8% | 1,365,570 | +4.0% | 0.00% | 0.0% |
| Q2 2017 | $9,494,000 | +41.9% | 1,313,096 | +4.0% | 0.00% | 0.0% |
| Q1 2017 | $6,691,000 | -27.2% | 1,262,403 | -1.3% | 0.00% | 0.0% |
| Q4 2016 | $9,185,000 | -16.0% | 1,279,309 | +9.5% | 0.00% | -33.3% |
| Q3 2016 | $10,931,000 | +50.3% | 1,167,823 | +1.5% | 0.00% | +50.0% |
| Q2 2016 | $7,271,000 | +20.0% | 1,150,499 | +4.8% | 0.00% | 0.0% |
| Q1 2016 | $6,057,000 | -55.9% | 1,097,302 | -55.5% | 0.00% | -50.0% |
| Q4 2015 | $13,744,000 | -62.7% | 2,463,097 | -43.4% | 0.00% | -60.0% |
| Q3 2015 | $36,814,000 | -3.4% | 4,351,593 | +72.6% | 0.01% | 0.0% |
| Q2 2015 | $38,117,000 | -30.0% | 2,520,949 | -25.9% | 0.01% | -28.6% |
| Q1 2015 | $54,489,000 | -16.7% | 3,403,414 | -7.2% | 0.01% | -17.6% |
| Q4 2014 | $65,386,000 | +73.6% | 3,669,288 | -2.2% | 0.02% | +70.0% |
| Q3 2014 | $37,654,000 | +12.8% | 3,750,435 | +75.4% | 0.01% | +11.1% |
| Q2 2014 | $33,386,000 | +40.4% | 2,138,735 | +66.9% | 0.01% | +28.6% |
| Q1 2014 | $23,782,000 | +173.8% | 1,281,335 | +181.7% | 0.01% | +250.0% |
| Q4 2013 | $8,687,000 | +17.7% | 454,785 | +0.7% | 0.00% | 0.0% |
| Q3 2013 | $7,382,000 | -6.9% | 451,785 | -56.9% | 0.00% | -33.3% |
| Q2 2013 | $7,933,000 | – | 1,049,390 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|